Bente Kierulf

Bente Kierulf

Auto-generated profile, based on publicly available information

Bente Kierulf

Regional Research Network on Extracellular Vesicles, South-Eastern Norway Regional Health Authority, Norway

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2017 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
BVBeate Vestad
Beate Vestad
ALAlicia M. Llorente
Alicia M. Llorente
ANAxl Neurauter
Axl Neurauter
SPSantosh Phuyal
Santosh Phuyal
BKBente Kierulf
Bente Kierulf
RØReidun Øvstebø
Reidun Øvstebø
Current methods for characterisation of extracellular vesicles (EVs) need further standardisation in order to obtain an acceptable level of data comparability. Size and concentration of EVs can be determined by nanoparticle tracking analysis (NTA). However, both the heterogeneity of EVs and the choice of instrument settings may cause an appreciable analytical variation. Intra‐assay (within‐day, n = 6) and inter‐assay (day‐to‐day, n = 6) variations (coefficient of variation, % CV) of different preparations of EVs and artificial vesicles or beads were determined using two NanoSight NS500 instruments, located at different laboratories. All analyses were performed by the same operator. The effect of applying identical software settings or instrument‐optimised settings for each sample type and instrument was also evaluated. Finally, the impact of different operators and the use of two different software versions were investigated. The intra‐assay CVs were 1–12% for both EVs and artificial samples, measured on the same instrument. The overall day‐to‐day variation was similar for both instruments, ranging from 2% to 25%. However, significantly different results were observed between the two instruments using identical software settings. The effect of applying instrument‐optimised settings reduced the mismatch between the instruments, resulting in little to no significant divergences. The impact of using different operators and software versions when analysing silica microspheres and microvesicles from monocytes using instrument‐optimised settings on the same instrument did not contribute to significant variation compared to the overall day‐to‐day variation of one operator. Performance differences between two similar NTA instruments may display significant divergences in size and concentration measurements when analysing EVs, depending on applied instrument settings and technical conditions. The importance of developing a streamlined and standardised execution of analysis, as well as monitoring longitudinal variation parameters on both biological and synthetic samples, should be highlighted.

1 October 1993 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
JFJ Frengen
J Frengen
RSR Schmid
R Schmid
BKB Kierulf
B Kierulf
KNK Nustad
K Nustad
EPE Paus
E Paus
TLT Lindmo
T Lindmo
We evaluated two homogeneous immunofluorometric assays (IFMAs) of alpha-fetoprotein (AFP) based on new macroporous acrylate particles combined with flow cytometry. The standard IFMA, requiring 1 h of incubation, provided a working range from 1.8 to > 900 kIU/L (CV < 10%) and a detection limit of 0.6 kIU/L. Use of overnight incubation and a lower particle concentration extended the working range by 1 decade in the lower end. Analytical recoveries for the standard IFMA varied between 97% and 108%. The slope and y-intercept of the regression line correlating measurements by the standard IFMA and a routine immunoradiometric assay were not significantly different from 1 and 0, respectively (P > 0.5), and the correlation coefficient was 0.996. High precision and warning of spuriously high measurements were obtained by including in each sample separate particle types for detecting instrument instability and measuring nonspecific binding only.